An observational study in Cognitive Dysfunction, sponsored by National Sun Yat-sen University. Recruiting at 1 site in Taiwan. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-15.
Sponsored by National Sun Yat-sen University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 111 studies in Cognitive Dysfunction with a site in Taiwan — 24 open to participants now, 29 under way, 3 of them phase 3. Cognitive Dysfunction · Taiwan.
Among the 111 studies in Cognitive Dysfunction with a site in Taiwan, this one is the 6th largest by planned enrollment of the 17 observational ones that give a count, is one of 5 that started in 2026, is one of 17 observational ones, reaches primary completion later than 13 of the 28 other live ones, and was the 104th registered.
3,885 studies on the registry are indexed under Cognitive Dysfunction; 1,123 are open to participants now.
Browse Cognitive Dysfunction studies →24 of the 111 studies in Cognitive Dysfunction with a site in Taiwan are open now. Recruiting first, the newest first:
National Cheng-Kung University Hospital · Sites in Taiwan
Ages 30–85
Eli Lilly and Company · Sites in Taiwan, United States, Japan and 1 more country
Ages 55–85
Stichting International Registry for Alzheimer's Disease and other Dementias Foundation · Sites in Taiwan, Australia, Austria and 14 more countries
Ages 18+
Cheng-Hsin General Hospital · Sites in Taiwan
Ages 65–90
Chang Gung Memorial Hospital · Sites in Taiwan
Ages 50+ · Healthy volunteers
A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →
Of the 751 Cognitive Dysfunction studies recruiting now, 361 (48%) set no upper age limit and 144 (19%) stop at 75 or younger; 46 take children under 18; 260 take healthy volunteers.
This study: 65 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
111 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 5 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 210 is above the median of 150 across 1,000 observational studies indexed under Cognitive Dysfunction.
Median enrollment 62 across the 94 interventional studies, 192 across the 17 observational. Of the 60 that completed or were terminated, 1 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 111 have an industry lead sponsor. The 10 most frequent:
National Sun Yat-sen University is the lead sponsor of 6 studies on the registry; 5 are open to participants now.
National Sun Yat-sen University has 1 study filed under Cognitive Dysfunction — fewer than ten, so there is no comparison to draw.
5 of the studies in Cognitive Dysfunction with a site in Taiwan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07358598National Sun Yat-sen UniversityEye Movement Parameters and Cognitive Functions in Older Adults | 2026-12-31 |
| NCT05830903National Taiwan University HospitalDevelop a Novel Occupational Training Program for Schizophrenia Patients Based on Virtual Reality Techniques | 2026-12-31 |
| NCT06902181China Medical University HospitalObservation of Inhalation of CXMCI-01 Essential Oil on Patients With Mild Cognitive Impairment | 2027-02 |
| NCT06467539Chang Gung Memorial HospitalNovel Augmentation of DAOIB and Antioxidant for Early Dementia | 2027-05 |
| NCT05448768Chang Gung Memorial HospitalCognitive Effects and Potential Mechanisms of TBS in Subjects With MCI | 2027-06-30 |
Add all 5 to your calendar (.ics) → With an account.
Among the 111 studies in Cognitive Dysfunction with a site in Taiwan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Dementia most commonly occurs in elderly individuals, but currently there is still a lack of objective measurement methods that can detect cognitive impairment in older adults at an early stage. Eye movement is considered a clinical indicator with potential for screening mild cognitive dysfunction, and eye movement signals can be extracted to objectively evaluate cognition. Eye tracking has been used mostly to evaluate patients with neurodegenerative diseases such as Parkinson's disease. However, less attention has been paid to the relationship between eye movement and cognitive function in elderly individuals, as well as the association between eye movement data and abnormal cognitive subdomains. This cross-sectional study will recruit 0204 elderly individuals over the age of 65, divided into three groups (healthy group/mild cognitive impairment group/dementia group) according to the purpose of this study. Participants who have not been diagnosed with neurological diseases (such as Parkinson's disease or stroke), or have mental illness or visual impairments will be excluded. This study hopes to provide empirical data on eye movement signals and cognitive function in healthy older individuals, as well as to serve as a preliminary study for future development of eye activity stimulation to improve cognitive function in older adults.
A total of 210 participants will be recruited, with an estimated 70 individuals in each cognitive group.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
- Participants are aged 65 years or older and have completed a comprehensive geriatric assessment (CGA) in the outpatient clinic.
Exclusion Criteria:
Eye-tracking measurement
Eye movement behavior will be assessed as an objective measure of cognitive control in older adults. Eye-tracking data will be collected using the J7EF Gaze Smart Glasses (Jorjin Technologies), a non-invasive wearable eye-tracking system with a sampling frequency of 30 Hz. Participants will perform standardized visual tasks while eye movement behavior is recorded. Outcome measures will include task-related eye movement patterns, such as gaze behavior and saccadic performance, which reflect attentional control and higher-order cognitive processing. Alterations in these eye movement parameters have been associated with cognitive impairment. Eye movement measures will be used to characterize differences in cognitive function across participant groups.
Time frame: A single assessment is conducted at one study visit (cross-sectional design).
Mini-Mental State Examination (MMSE)
The Mini-Mental State Examination (MMSE) is a widely used cognitive screening tool originally developed by Folstein and McHugh in 1975 (Folstein et al., 1975). It consists of 30 items assessing six domains of cognitive function: orientation, attention, memory, language, verbal comprehension, praxis, and constructional ability. Higher scores indicate better cognitive function. A total score between 24 and 30 suggests intact cognitive function; scores between 18 and 23 are indicative of mild cognitive impairment; and scores from 0 to 17 reflect moderate to severe cognitive impairment. In the present study, the MMSE is used to classify adults aged 65 years and older into cognitive status groups, including a cognitively healthy group, a mild cognitive impairment (MCI) group, and a dementia group, based on established score thresholds.
Time frame: A single assessment is conducted at one study visit (cross-sectional design).
Eye-Tracking Task 1: Horizontal Fixation Task (HFT)
The FXS task is designed to measure fixation stability. Participants are instructed to fixate on a white dot, that appears sequentially at different screen locations: initially in the center, then alternately to the left and right sides of the screen.Each position is maintained for 5 seconds, during which participants are instructed to maintain their gaze on the white dot. The sequence proceeds as follows: Center (5 seconds), right side (5 seconds), left side (5 seconds), and return to center (5 seconds). The task duration is approximately 20 seconds.
Time frame: A single assessment is conducted at one study visit (cross-sectional design).
Eye-Tracking Task 2: Vertical Fixation Task (VFT)
The Vertical Fixation Task is designed to assess vertical saccadic eye movements and fixation stability. A white fixation dot is sequentially displayed on a black background at specific vertical locations. The target is presented at the center of the screen and then alternates between upper and lower positions at 5-second intervals (center-upper-lower-center), with a total task duration of approximately 20 seconds.
Time frame: A single assessment is conducted at one study visit (cross-sectional design).
Eye-tracking Task 3: Horizontal Pursuit Task (HPT)
The HPT is designed to evaluate participants' ability to perform smooth horizontal pursuit eye movements. A white dot then appears at the center of a black screen, prompting participants to fixate and track the dot continuously as it begins moving horizontally. The stimulus moves smoothly and repeatedly from left to right and back across the screen. Participants are instructed to visually follow the moving dot toward to left and right side without shifting their head position. The task duration is approximately 30 seconds.
Time frame: A single assessment is conducted at one study visit (cross-sectional design).
Eye-Tracking Task 4: Vertical Pursuit Task (VPT)
The VPT is designed to evaluate participants' ability to perform smooth horizontal pursuit eye movements. A white dot then appears at the center of a black screen, prompting participants to fixate and track the dot continuously as it begins moving vertically. The stimulus moves smoothly and repeatedly from up to down across the screen. Participants are instructed to visually follow the moving dot toward to up and down side without shifting their head position. The task duration is approximately 30 seconds.
Time frame: A single assessment is conducted at one study visit (cross-sectional design).
Eye-Tracking Task 5: Horizontal Saccade Task (HST)
The HST is designed to evaluate rapid, reflexive saccadic eye movements in response to abrupt horizontal target shifts. A white fixation dot appears at the center of the screen and then jumps alternately between the far left and far right positions. Participants are instructed to track the dot continuously from left to right for the entire duration of the task (approximately 30 seconds). Each positional shift is abrupt, requiring quick and accurate horizontal saccades.
Time frame: A single assessment is conducted at one study visit (cross-sectional design).
Eye-Tracking Task 6: Vertical Saccade Task (VST)
The VST is designed to evaluate rapid, reflexive saccadic eye movements in response to abrupt horizontal target shifts. A white fixation dot appears at the center of the screen and then jumps alternately between the far up and far down positions. Participants are instructed to track the dot continuously from up to down for the entire duration of the task (approximately 30 seconds). Each positional shift is abrupt, requiring quick and accurate horizontal saccades.
Time frame: A single assessment is conducted at one study visit (cross-sectional design).
Plan to share: No
Started Jan 2026 (actual). Primary completion is estimated for Dec 2026, 11 months after the start.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Sun Yat-sen University